Literature DB >> 9441089

Progress in the development of new vaccines against tuberculosis.

I M Orme1.   

Abstract

The last few years have seen a re-emergence of interest in developing new vaccines against tuberculosis. The present article briefly reviews progress in this field, which has seen the development of several highly innovative new approaches, including the use of plasmid DNA vector-based vaccines, recombinant and mutant BCG vaccines, and sub-unit vaccines.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9441089

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


  7 in total

1.  Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode.

Authors:  J Turner; E R Rhoades; M Keen; J T Belisle; A A Frank; I M Orme
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Vaccination of guinea pigs with nutritionally impaired avirulent mutants of Mycobacterium bovis protects against tuberculosis.

Authors:  G W De Lisle; T Wilson; D M Collins; B M Buddle
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis.

Authors:  S L Baldwin; C D'Souza; A D Roberts; B P Kelly; A A Frank; M A Lui; J B Ulmer; K Huygen; D M McMurray; I M Orme
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis.

Authors:  Lise Brandt; Joana Feino Cunha; Anja Weinreich Olsen; Ben Chilima; Penny Hirsch; Rui Appelberg; Peter Andersen
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

5.  Genetically susceptible mice remain proportionally more susceptible to tuberculosis after vaccination.

Authors:  E Medina; R J North
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

6.  The tuberculosis epidemic. Scientific challenges and opportunities.

Authors:  A M Ginsberg
Journal:  Public Health Rep       Date:  1998 Mar-Apr       Impact factor: 2.792

7.  Characterization of recombinant B. abortus strain RB51SOD toward understanding the uncorrelated innate and adaptive immune responses induced by RB51SOD compared to its parent vaccine strain RB51.

Authors:  Jianguo Zhu; Charles B Larson; Megan Ann Ramaker; Kimberly Quandt; Jered M Wendte; Kimberly P Ku; Fang Chen; George W Jourdian; Ramesh Vemulapalli; Gerhardt G Schurig; Yongqun He
Journal:  Front Cell Infect Microbiol       Date:  2011-11-25       Impact factor: 5.293
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.